Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
The Toronto-Dominion Bank
TD
5
Power Corporation of Canada
POW
CA Stock MarketDetailed Quotes
LLY Eli Lilly CDR (CAD Hedged)
- 27.270
- -1.960-6.71%
15min DelayMarket Closed Apr 4 15:58 ET
897.72BMarket Cap59.41P/E (TTM)
28.390High27.170Low54.56KVolume28.340Open29.230Pre Close1.50MTurnover36.29752wk High0.01%Turnover Ratio32.92BShares26.53452wk Low0.459EPS TTM24.43BFloat Cap36.297Historical High59.41P/E (Static)895.76MShs Float19.390Historical Low0.459EPS LYR4.17%Amplitude0.20Dividend TTM44.49P/B1Lot Size0.75%Div YieldTTM
About Eli Lilly CDR (CAD Hedged) Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Company Profile
SymbolLLY
Company NameEli Lilly CDR (CAD Hedged)
Founded1901
MarketNEOE
Employees47000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
CountryUnited States of America
Zip Code46285
Phone+1 317 276-2000
Websitehttps://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 29.24M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- 2.95M
- Eric Dozier
- Executive Vice President and Chief People Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Dr. Daniel M. Skovronsky, M.D.,PhD
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 12.64M
- Melissa Seymour
- Executive Vice President, Global Quality
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.48M
- Patrik Jonsson
- Executive Vice President and President, Lilly Cardiometabolic Health; President, Lilly USA
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Lilly Oncology
- 5.77M
- Ilya Yuffa
- Executive Vice President; President, Lilly International
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Kimberly H. Johnson
- Independent Director
- 336.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 366.75K
- Ralph Alvarez
- Independent Director
- 361.00K
- Juan R. Luciano
- Lead Independent Director
- 398.00K
- Jon R. Moeller
- Independent Director
- 9.92K
- Jon Erik Fyrwald
- Independent Director
- 386.55K
- Jamere Jackson
- Independent Director
- 365.00K
- Dr. William G. Kaelin, Jr,M.D.
- Independent Director
- 400.15K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 339.00K
- Dr. Katherine Baicker, PhD
- Independent Director
- 361.00K
Market Insights
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.
Unlock Now
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.
Unlock Now